Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine. [electronic resource]
Producer: 20200727Description: 1052-1059 p. digitalISSN:- 1751-1097
- Aminolevulinic Acid -- administration & dosage
- Breast Neoplasms
- Cell Line, Tumor
- Deferoxamine -- pharmacology
- Epithelial Cells
- Female
- Ferrochelatase -- genetics
- Gene Silencing
- Humans
- Photochemotherapy -- methods
- Photosensitizing Agents -- administration & dosage
- Protoporphyrins -- administration & dosage
- Siderophores -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.